STAT3 and neoplasm: Interestingly, administration of the natural napthoquinone compound shikonin has been demonstrated to reduce the in vivo growth of tumours that are derived from implantation of 4T1 cells, and this is suggested to be through modulation of STAT3 and Oct3/4 expression [83].